TechMARK movers: Planned cash call from Oxford Biomedica

13th Dec 2010 13:11

Oxford Biomedica intends to raise up to £20m at a significant discount to Friday's closing price. The gene-based therapies developer is offering existing shareholders the opportunity to subscribe for two new shares for every nine they hold at 5p a share. The rest of the cash will come from a firm placing. Software company Autonomy says that it has signed a $13m plus contract with a leading media company. No time scale was indicated. FTSE TechMARK - RisersAsterand (ATD) 15.50p +5.08%RM (RM.) 155.00p +4.73%Xaar (XAR) 237.50p +4.17%NXT (NTX) 3.50p +3.55%Micro Focus International Plc (MCRO) 396.70p +2.72%Skyepharma (SKP) 32.50p +2.36%Autonomy Corporation (AU.) 1,406.00p +2.11%Corin Group (CRG) 46.00p +1.66%Oxford Instruments (OXIG) 675.50p +1.43%AEA Technology Group (AAT) 5.55p +1.28%FTSE TechMARK - FallersOxford Biomedica (OXB) 6.82p -14.75%Antisoma (ASM) 6.00p -5.51%Consort Medical (CSRT) 460.75p -3.41%Kewill (KWL) 88.00p -3.30%Emblaze Ltd. (BLZ) 46.25p -2.63%Filtronic (FTC) 35.50p -2.07%Gresham Computing (GHT) 24.50p -2.00%Promethean World (PRW) 57.00p -1.72%Innovation Group (TIG) 15.00p -1.64%Vectura Group (VEC) 67.25p -1.47%